Summary
23.50 1.35(6.09%)08/30/2024
Progyny Inc (PGNY)
Progyny Inc (PGNY)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 6.09 | 1.00 | -24.97 | -18.31 | -37.19 | -41.02 | 0.00 | 36.54 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 23.50 | |
| Open | 22.26 | |
| High | 23.51 | |
| Low | 22.26 | |
| Volume | 2,478,607 | |
| Change | 1.35 | |
| Change % | 6.09 | |
| Avg Volume (20 Days) | 1,248,383 | |
| Volume/Avg Volume (20 Days) Ratio | 1.99 | |
| 52 Week Range | 19.60 - 42.08 | |
| Price vs 52 Week High | -44.15% | |
| Price vs 52 Week Low | 19.90% | |
| Range | 1.14 | |
| Gap Up/Down | -0.23 | |
Fundamentals | ||
| Market Capitalization (Mln) | 2,121 | |
| EBIDTA | 41,224,000 | |
| PE Ratio | 52.0397 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 70.29 | |
| Book Value | 2.4900 | |
| Earnings Per Share | 0.9070 | |
| EPS Estimate Current Quarter | 0.0600 | |
| EPS Estimate Next Quarter | 0.0700 | |
| EPS Estimate Current Year | 0.5300 | |
| EPS Estimate Next Year | 0.5600 | |
| Diluted EPS (TTM) | 0.9070 | |
| Revenues | ||
| Profit Marging | 0.1896 | |
| Operating Marging (TTM) | 0.0840 | |
| Return on asset (TTM) | 0.0923 | |
| Return on equity (TTM) | 0.5109 | |
| Revenue TTM | 473,368,992 | |
| Revenue per share TTM | 5.3700 | |
| Quarterly Revenue Growth (YOY) | 0.2360 | |
| Quarterly Earnings Growth (YOY) | 2.4000 | |
| Gross Profit (TTM) | 70,059,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 52.0397 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 18.8839 | |
| Revenue Enterprise Value | 8.7151 | |
| EBITDA Enterprise Value | 117.4078 | |
| Shares | ||
| Shares Outstanding | 90,430,304 | |
| Shares Float | 70,600,741 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 5.43 | |
| Institutions (%) | 94.01 | |
08/16 07:57 EST - benzinga.com
Top 3 Health Care Stocks That Are Set To Fly This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Top 3 Health Care Stocks That Are Set To Fly This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
08/15 13:32 EST - seekingalpha.com
Progyny: Downgrading As Uncertainties Increase
Progyny lowered full-year revenue guidance after seeing an unexpected drop in user utilization rates. The Harris-Walz ticket has put fertility benefits center stage in the upcoming presidential election which makes the stock more volatile in the short-term. Despite current challenges, Progyny's long-term growth thesis remains intact with potential opportunities for expansion in the future.
Progyny: Downgrading As Uncertainties Increase
Progyny lowered full-year revenue guidance after seeing an unexpected drop in user utilization rates. The Harris-Walz ticket has put fertility benefits center stage in the upcoming presidential election which makes the stock more volatile in the short-term. Despite current challenges, Progyny's long-term growth thesis remains intact with potential opportunities for expansion in the future.
08/08 09:13 EST - fool.com
Progyny EPS Outperforms, Revenue Dips in Q2
Revenue of $304.1 million met management's expectations. Adjusted EPS of $0.43 outperformed management's guidance.
Progyny EPS Outperforms, Revenue Dips in Q2
Revenue of $304.1 million met management's expectations. Adjusted EPS of $0.43 outperformed management's guidance.
08/07 13:48 EST - fool.com
Why Progyny Stock Dropped Today
Progyny missed analysts' revenue expectations for the second quarter by a tiny margin. Making matters worse, the company cut sales growth guidance from 15% to 8.5% for 2024.
Why Progyny Stock Dropped Today
Progyny missed analysts' revenue expectations for the second quarter by a tiny margin. Making matters worse, the company cut sales growth guidance from 15% to 8.5% for 2024.
08/06 22:35 EST - seekingalpha.com
Progyny, Inc. (PGNY) Q2 2024 Earnings Call Transcript
Progyny, Inc. (PGNY) Q2 2024 Earnings Call Transcript
Progyny, Inc. (PGNY) Q2 2024 Earnings Call Transcript
Progyny, Inc. (PGNY) Q2 2024 Earnings Call Transcript
08/06 21:05 EST - zacks.com
Progyny (PGNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Progyny (PGNY) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Progyny (PGNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Progyny (PGNY) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
08/06 18:37 EST - zacks.com
Progyny (PGNY) Beats Q2 Earnings Estimates
Progyny (PGNY) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.15 per share a year ago.
Progyny (PGNY) Beats Q2 Earnings Estimates
Progyny (PGNY) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.15 per share a year ago.
08/06 16:02 EST - globenewswire.com
Progyny, Inc. Announces Second Quarter 2024 Results
Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion RateBoard Authorizes Repurchase of $100 Million of Common Stock
Progyny, Inc. Announces Second Quarter 2024 Results
Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion RateBoard Authorizes Repurchase of $100 Million of Common Stock
07/30 11:06 EST - zacks.com
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
07/12 06:32 EST - globenewswire.com
Assisted Reproductive Technology Market Report 2024-2033: Vitrolife Leads the Competition with 9.8% Share, Followed by Ferring, and Progyny
Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "Assisted Reproductive Technology Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. The global assisted reproductive technology market reached a value of nearly $37.6 billion in 2023, having grown at a compound annual growth rate (CAGR) of 5.6% since 2018. The market is expected to grow from $37.6 billion in 2023 to $55.91 billion in 2028 at a rate of 8.3%. The market is then expected to grow at a CAGR of 8.4% from 2028 and reach $83.8 billion in 2033.
Assisted Reproductive Technology Market Report 2024-2033: Vitrolife Leads the Competition with 9.8% Share, Followed by Ferring, and Progyny
Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "Assisted Reproductive Technology Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. The global assisted reproductive technology market reached a value of nearly $37.6 billion in 2023, having grown at a compound annual growth rate (CAGR) of 5.6% since 2018. The market is expected to grow from $37.6 billion in 2023 to $55.91 billion in 2028 at a rate of 8.3%. The market is then expected to grow at a CAGR of 8.4% from 2028 and reach $83.8 billion in 2033.
06/26 13:42 EST - globenewswire.com
Progyny, Inc. to Host 2024 Inaugural Investor Day
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time until approximately 1:00 P.M. Eastern Time.
Progyny, Inc. to Host 2024 Inaugural Investor Day
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time until approximately 1:00 P.M. Eastern Time.
06/24 07:00 EST - globenewswire.com
Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded in 2019. This acquisition enhances Progyny's guided, concierge support that enables employees around the world to navigate the complexities of fertility and family building care.
Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded in 2019. This acquisition enhances Progyny's guided, concierge support that enables employees around the world to navigate the complexities of fertility and family building care.
06/11 11:00 EST - prnewswire.com
Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth
Kindbody is the Largest Women-founded, Women-led Fertility Company Serving Employers and Families through its National Clinic Network and Proprietary Technology Platform NEW YORK, June 11, 2024 /PRNewswire/ -- Kindbody , the leading national fertility clinic network and global family-building benefits provider for employers, today announced its Founder and Executive Chairman, Gina Bartasi, will return as the company's CEO during a time of unprecedented growth. The Company recently shared that it expected to deliver revenue in the range of $225-$250 million for 2024 and is now profitable after years of significant investment into new clinic locations and proprietary technology.
Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth
Kindbody is the Largest Women-founded, Women-led Fertility Company Serving Employers and Families through its National Clinic Network and Proprietary Technology Platform NEW YORK, June 11, 2024 /PRNewswire/ -- Kindbody , the leading national fertility clinic network and global family-building benefits provider for employers, today announced its Founder and Executive Chairman, Gina Bartasi, will return as the company's CEO during a time of unprecedented growth. The Company recently shared that it expected to deliver revenue in the range of $225-$250 million for 2024 and is now profitable after years of significant investment into new clinic locations and proprietary technology.
06/10 03:22 EST - seekingalpha.com
Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore
Progyny finds itself in an industry enjoying numerous secular tailwinds that they are well-positioned to capitalize on. The company reported Q1'24 on the 9th of May, with the stock plummeting around 15% after reporting a revenue miss. This presents an attractive entry point, with a conservatively estimated 49-76% upside.
Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore
Progyny finds itself in an industry enjoying numerous secular tailwinds that they are well-positioned to capitalize on. The company reported Q1'24 on the 9th of May, with the stock plummeting around 15% after reporting a revenue miss. This presents an attractive entry point, with a conservatively estimated 49-76% upside.
06/04 15:00 EST - globenewswire.com
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 9:00 A.M. Eastern Time.
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 9:00 A.M. Eastern Time.
06/03 22:01 EST - seekingalpha.com
Progyny: No Change To Long-Term Outlook
PGNY experienced a revenue miss in 1Q24 due to weak utilization. Historical data shows that IVF demand has been resilient, with strong rebounds following economic downturns. Leading indicators suggest that utilization rates are already improving, and demand remains solid, indicating potential for growth acceleration in the coming quarters.
Progyny: No Change To Long-Term Outlook
PGNY experienced a revenue miss in 1Q24 due to weak utilization. Historical data shows that IVF demand has been resilient, with strong rebounds following economic downturns. Leading indicators suggest that utilization rates are already improving, and demand remains solid, indicating potential for growth acceleration in the coming quarters.
05/22 17:30 EST - marketwatch.com
Progyny's board approves another $100 million stock buyback
The board of Progyny PGNY, -2.62% has approved a $100 million share-repurchase authorization, its second this year.
Progyny's board approves another $100 million stock buyback
The board of Progyny PGNY, -2.62% has approved a $100 million share-repurchase authorization, its second this year.
05/22 17:00 EST - globenewswire.com
Progyny, Inc. Announces Additional Share Repurchase Program
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common stock. This follows the program that was previously announced on February 29, 2024. The program will be funded through available cash balances.
Progyny, Inc. Announces Additional Share Repurchase Program
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common stock. This follows the program that was previously announced on February 29, 2024. The program will be funded through available cash balances.
05/14 11:00 EST - globenewswire.com
Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Progyny's executives will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 5:00 P.M. Pacific Time / 8:00 P.M. Eastern Time. They will also participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference 2024 on Wednesday, May 29, 2024, at 1:00 P.M. Central Time / 2:00 P.M. Eastern Time.
Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Progyny's executives will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 5:00 P.M. Pacific Time / 8:00 P.M. Eastern Time. They will also participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference 2024 on Wednesday, May 29, 2024, at 1:00 P.M. Central Time / 2:00 P.M. Eastern Time.
05/10 10:11 EST - marketwatch.com
Progyny's stock plunges as demand for IVF treatments drops after Alabama ruling
Shares of Progyny Inc. were headed for a record selloff Friday after the fertility-services company said the Supreme Court of Alabama's February ruling regarding in vitro fertilization seemed to scare off some potential customers.
Progyny's stock plunges as demand for IVF treatments drops after Alabama ruling
Shares of Progyny Inc. were headed for a record selloff Friday after the fertility-services company said the Supreme Court of Alabama's February ruling regarding in vitro fertilization seemed to scare off some potential customers.